Instil Bio
Jon Mabbett has extensive experience in supply chain business applications and systems management. Currently serving as Senior Manager of Supply Chain Business Applications at Instil Bio, Jon has previously held roles such as Business Systems Manager at Chiesi USA, Inc., SAP System Owner at Argos Therapeutics, and Senior Global Supply Chain Systems Architect at Eisai. Jon completed education at the University of Bath, further enhancing expertise in the field.
This person is not in any offices
Instil Bio
1 followers
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.